Literature DB >> 32305657

Gluten exacerbates atherosclerotic plaque formation in ApoE-/- mice with diet-induced obesity.

Edenil Costa Aguilar1, Juliana Maria Navia-Pelaez2, Weslley Fernandes-Braga3, Fabíola Lacerda Pires Soares4, Lana Claudinez Dos Santos3, Alda Jusceline Leonel3, Luciano Dos Santos Aggum Capettini5, Rafael Pires de Oliveira6, Ana Maria Caetano de Faria3, Virginia Soares Lemos7, Jacqueline I Alvarez-Leite3.   

Abstract

OBJECTIVES: Atherosclerosis is an underlying cause of cardiovascular disease, and obesity is one of the risk factors for atherogenesis. Although a gluten-free diet (GFD) has gained popularity as a strategy for weight loss, little is known about the effects of gluten on obesity. We have previously shown a negative effect of gluten on obesity in mice. However, its effects on atherogenesis are still unknown. Therefore, the aim of this study was to determine the effects of gluten on atherosclerosis progression during obesity.
METHODS: Atherosclerosis-susceptible ApoE knockout mice were subjected to an obesogenic GFD or a diet with 4.5% gluten (GD) for 10 wk.
RESULTS: Results from the study found that food intake and lipid profile were similar between the groups. However, GD promoted an increase in weight gain, adiposity, and plasma glucose. Pro-inflammatory factors such as tumor necrosis factor, interleukin-6, chemokine ligand-2, and matrix metalloproteinase-2 and -9 also were increased in the adipose tissue of gluten-fed mice. This inflammatory profile was associated with reduced phosphorylation of Akt, and consequently with the intensification of insulin resistance. The GD-enhanced vascular inflammation contributed to the worsening of atherosclerosis in the aorta and aortic root. Inflammatory cells, such as monocyte/macrophage and natural killer cells, and oxidative stress markers, such as superoxide and nitrotyrosine, were increased in atherosclerotic lesions of the GD group. Furthermore, the lesions presented higher necrotic core and lower collagen content, characterizing the less stable plaques.
CONCLUSION: The gluten-containing high-fat diet was associated with a more severe proatherogenic profile than the gluten-free high-fat diet owing to increased inflammatory and oxidative status at atherosclerotic lesions in obese mice.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adipose tissue inflammation; Insulin signaling; Obesity; Vascular inflammation

Mesh:

Substances:

Year:  2019        PMID: 32305657     DOI: 10.1016/j.nut.2019.110658

Source DB:  PubMed          Journal:  Nutrition        ISSN: 0899-9007            Impact factor:   4.008


  4 in total

1.  Mammalian STE20-Like Kinase 2 Promotes Lipopolysaccharides-Mediated Cardiomyocyte Inflammation and Apoptosis by Enhancing Mitochondrial Fission.

Authors:  Yanan Tian; Haijiu Song; Wei Qin; Zhenjiang Ding; Ying Zhang; Weichao Shan; Dapeng Jin
Journal:  Front Physiol       Date:  2020-08-06       Impact factor: 4.755

Review 2.  Impact of Lifestyles (Diet and Exercise) on Vascular Health: Oxidative Stress and Endothelial Function.

Authors:  Andy W C Man; Huige Li; Ning Xia
Journal:  Oxid Med Cell Longev       Date:  2020-09-26       Impact factor: 6.543

Review 3.  Diets and Cellular-Derived Microparticles: Weighing a Plausible Link With Cerebral Small Vessel Disease.

Authors:  Che Mohd Nasril Che Mohd Nassir; Mazira Mohamad Ghazali; Sabarisah Hashim; Nur Suhaila Idris; Lee Si Yuen; Wong Jia Hui; Haziq Hazman Norman; Chuang Huei Gau; Nanthini Jayabalan; Yuri Na; Linqing Feng; Lin Kooi Ong; Hafizah Abdul Hamid; Haja Nazeer Ahamed; Muzaimi Mustapha
Journal:  Front Cardiovasc Med       Date:  2021-02-24

4.  Influence of APOE locus on poor prognosis of COVID-19.

Authors:  Juliana Carla Gomes Rodrigues; Pablo Pinto; Luciana Pereira Colares Leitão; Lui Wallacy Morikawa Souza Vinagre; Natasha Monte; Marianne Rodrigues Fernandes; André Salim Khayat; Paulo Pimentel de Assumpção; Ney Pereira Carneiro Dos Santos; Sidney Emanuel Batista Dos Santos
Journal:  Heliyon       Date:  2021-06-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.